Kornstein SG - Search Results

1

Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.

Andrews PW, Kornstein SG, Halberstadt LJ, Gardner CO, Neale MC. Andrews PW, et al. Among authors: kornstein sg. Front Psychol. 2011 Jul 7;2:159. doi: 10.3389/fpsyg.2011.00159. eCollection 2011. Front Psychol. 2011. PMID: 21779273 Free PMC article.

2

Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction.

McCullough JP Jr, Klein DN, Keller MB, Holzer CE 3rd, Davis SM, Kornstein SG, Howland RH, Thase ME, Harrison WM. McCullough JP Jr, et al. Among authors: kornstein sg. J Abnorm Psychol. 2000 Aug;109(3):419-27. J Abnorm Psychol. 2000. PMID: 11016111

3

Enhancing pharmacologic effects in the treatment of depression in women.

Kornstein SG, McEnany G. Kornstein SG, et al. J Clin Psychiatry. 2000;61 Suppl 11:18-27. J Clin Psychiatry. 2000. PMID: 10926051 Review.

4

Gender differences in chronic major and double depression.

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB. Kornstein SG, et al. J Affect Disord. 2000 Oct;60(1):1-11. doi: 10.1016/s0165-0327(99)00158-5. J Affect Disord. 2000. PMID: 10940442

5

Clinical features of treatment-resistant depression.

Kornstein SG, Schneider RK. Kornstein SG, et al. J Clin Psychiatry. 2001;62 Suppl 16:18-25. J Clin Psychiatry. 2001. PMID: 11480880 Review.

6

Chronic depression in women.

Kornstein SG. Kornstein SG. J Clin Psychiatry. 2002 Jul;63(7):602-9. doi: 10.4088/jcp.v63n0713. J Clin Psychiatry. 2002. PMID: 12143919 Review.

7

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE. Kornstein SG, et al. J Clin Psychiatry. 2006 May;67(5):761-70. doi: 10.4088/jcp.v67n0510. J Clin Psychiatry. 2006. PMID: 16841626

8

Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study.

Kornstein SG. Kornstein SG. CNS Spectr. 2006 Dec;11(12 Suppl 15):28-34. doi: 10.1017/s1092852900015236. CNS Spectr. 2006. PMID: 17146416 Clinical Trial.

9

Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.

Kornstein SG. Kornstein SG. Expert Rev Neurother. 2008 May;8(5):737-42. doi: 10.1586/14737175.8.5.737. Expert Rev Neurother. 2008. PMID: 18457530 Review.

10

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

Kornstein SG, Kocsis JH, Ahmed S, Thase M, Friedman ES, Dunlop BW, Yan B, Pedersen R, Ninan PT, Li T, Keller M. Kornstein SG, et al. Int Clin Psychopharmacol. 2008 Nov;23(6):357-63. doi: 10.1097/YIC.0b013e328314e2cb. Int Clin Psychopharmacol. 2008. PMID: 18854724 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters